<p>Plasma samples from healthy endemic control (EC), <i>P</i>. <i>falciparum</i> patients (PF) and <i>P</i>. <i>vivax</i> patients (PV) were used in PvMSP1<sub>19</sub> or PfMSP1<sub>19</sub> ELISA, respectively. <b>A</b> and <b>B</b>: IgG levels in these samples for PvMSP1<sub>19</sub> (<b>A)</b> and PfMSP1<sub>19</sub> <b>(B)</b>. Data shown as median ± interquartile range were analyzed by one-way nonparametric Kruskal-Wallis test and Dunn's test for multiple comparisons. <b>C</b> and <b>D</b>: Prevalence of IgG positive samples for PvMSP1<sub>19</sub> <b>(C)</b> and PfMSP1<sub>19</sub> <b>(D)</b>. Data were analyzed by χ<sup>2</sup> test. OD cutoff value was defined as the average of non-endemic control samples plus two standard deviatio...
Background: Progress towards the development of a malaria vaccine against Plasmodium vivax, the most...
Background: The Plasmodium vivax merozoite surface protein 1 paralog (PvMSP1P-19) is a glycosylphosp...
<p>Each panel represents the reactivity index of serum samples against the indicated recombinant pro...
<p><b>A</b>) The bars express the percent response for each of the analyzed proteins. Sera from 220 ...
A) anti-PfGCS1 IgG antibody responses to rPfGCS1 antigen among plasma samples obtained from Iranian ...
<p><b>A.</b> Total and <i>Plasmodium vivax</i>-specific antibodies were measured by enzyme-linked im...
An important step when designing a vaccine is identifying the antigens that function as targets of n...
<p>Total and cytophilic IgG subclass (IgG1 & IgG3) levels of 273 individuals (<i>HBB</i> AS carriers...
<div><p>Understanding naturally acquired immunity to infections caused by <i>Plasmodia</i> in differ...
Plasmodium vivax malaria incidence has increased in Latin America and Asia and is responsible f...
<p>Immune recognition of <i>P. vivax</i> sporozoite antigen (A: PvCSP) and blood stage antigens (B: ...
In previous immuno-epidemiological studies of the naturally acquired antibody responses to merozoite...
Recently, we found that a recombinant protein based on the 19 kDa C-terminal region of the Plasmodiu...
<p>Immune recognition of <i>P. vivax</i> sporozoite antigen (A: PvCSP) and blood stage antigens (B: ...
In previous immuno-epidemiological studies of the naturally acquired antibody responses to merozoite...
Background: Progress towards the development of a malaria vaccine against Plasmodium vivax, the most...
Background: The Plasmodium vivax merozoite surface protein 1 paralog (PvMSP1P-19) is a glycosylphosp...
<p>Each panel represents the reactivity index of serum samples against the indicated recombinant pro...
<p><b>A</b>) The bars express the percent response for each of the analyzed proteins. Sera from 220 ...
A) anti-PfGCS1 IgG antibody responses to rPfGCS1 antigen among plasma samples obtained from Iranian ...
<p><b>A.</b> Total and <i>Plasmodium vivax</i>-specific antibodies were measured by enzyme-linked im...
An important step when designing a vaccine is identifying the antigens that function as targets of n...
<p>Total and cytophilic IgG subclass (IgG1 & IgG3) levels of 273 individuals (<i>HBB</i> AS carriers...
<div><p>Understanding naturally acquired immunity to infections caused by <i>Plasmodia</i> in differ...
Plasmodium vivax malaria incidence has increased in Latin America and Asia and is responsible f...
<p>Immune recognition of <i>P. vivax</i> sporozoite antigen (A: PvCSP) and blood stage antigens (B: ...
In previous immuno-epidemiological studies of the naturally acquired antibody responses to merozoite...
Recently, we found that a recombinant protein based on the 19 kDa C-terminal region of the Plasmodiu...
<p>Immune recognition of <i>P. vivax</i> sporozoite antigen (A: PvCSP) and blood stage antigens (B: ...
In previous immuno-epidemiological studies of the naturally acquired antibody responses to merozoite...
Background: Progress towards the development of a malaria vaccine against Plasmodium vivax, the most...
Background: The Plasmodium vivax merozoite surface protein 1 paralog (PvMSP1P-19) is a glycosylphosp...
<p>Each panel represents the reactivity index of serum samples against the indicated recombinant pro...